Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Medibio Ltd (MEB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.001 -0.001    -33.33%
12/08 - Closed. Currency in AUD ( Disclaimer )
  • Volume: 31,991
  • Bid/Ask: 0.001 / 0.002
  • Day's Range: 0.001 - 0.001
Type:  Equity
Market:  Australia
ISIN:  AU000000MEB8 
Medibio Ltd 0.001 -0.001 -33.33%
IndustryHealth Care Technology
SectorHealthcare
Employees

-

Equity Type

ORD

Medibio Limited is Australia-based health technology company. The principal activity of the Company is conducting clinical research, product development and early-stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. It is focused on early detection and screening of mental health conditions. Through their Corporate Health product, the Company offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. It has launched its consumer mobile app to help measure, monitor, and manage stress, called LUCA. LUCA is a biometric assessment tool that measures sleep stress, activity stress, and cardiac stress that allow consumers to monitor their daily stress levels through their own personal wearable device and provides science based learning modules to help manage their stress.

Contact Information

Phone 61 3 9692 7222
Fax 61 3 9077 9233

Top Executives

Name Age Since Title
Peter Carlisle - 2017 Chairman of Growth & Advocacy Advisory Board
Michael Fred Phelps - 2017 Member of Growth & Advocacy Advisory Board
Matthew Mesnik - 2014 Non-Executive Director
Patrick J. Kennedy - 2017 Member of Growth & Advocacy Advisory Board
Melanie Jaye Leydin 49 2018 Non-Executive Director
Elizabeth Lombardo - 2021 Member of Growth & Advocacy Advisory Board
Stephen Mitchley - 2022 Non-Executive Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MEB Comments

Write your thoughts about Medibio Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Henry Miles
Henry Miles 5 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Trading involves a lot of technicalities and strategies but banking with Mr's Harriet style ı earned much profits in 4 weeks of tradıng sessions. Credits to her Harriet j Hodson on Face📄book or what's👤App👉 +1 (214) 898-4365 for clinical delivery .her guidance strategies and execution plans are pretty fantastic
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email